Additionally, both in vivo and in vitro investigations have been demonstrated that combination therapy with estradiol and estrogen/norethisterone increases the overexpression of proliferation of progesterone receptor membrane component 1 in breast cancer cells 47. The gene discussed is PGRMC1; the disease is breast carcinoma.